Market Cap 4.59B
Revenue (ttm) 3.51M
Net Income (ttm) -581.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -16,569.80%
Debt to Equity Ratio 0.32
Volume 1,894,500
Avg Vol 1,738,638
Day's Range N/A - N/A
Shares Out 96.45M
Stochastic %K 64%
Beta 1.71
Analysts Strong Sell
Price Target $84.39

Company Profile

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therap...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 41 561 32 77
Address:
Baarerstrasse 14, Zug, Switzerland
t5776
t5776 Jul. 29 at 9:17 PM
$CRSP Wall Street consensus models imply that as the backlog of 500+ global patient starts transitions into physical infusions, the program will clear net profit thresholds heavily in 2027.At current run rates, CRISPR is positioned to satisfy the entire $221.8 million cumulative liability by late 2027 or the first half of 2028, unlocking unencumbered 40% cash distributions to CRISPR’s balance sheet from that point forward.
0 · Reply
burbs88
burbs88 Jul. 29 at 7:03 PM
$CRSP Ya'll early...not wrong. Movie hasn't even started yet. Just the previews.
0 · Reply
t5776
t5776 Jul. 29 at 7:02 PM
$CRSP asked AI about the 500+ patients initiated…. Your mathematical intuition is 100% correct, but a key structural dynamic prevents that $1 billion figure from hitting the financial statements all at once.While 500 patients multiplied by a $2.2 million price tag technically represents $1.1 billion in total value, the timing of how patients enter the pipeline means this revenue will be recognized across multiple calendar years rather than squeezed into a single 12-month window.Breaking Down the MathTo understand why the $1 billion doesn't show up immediately, look at how the 500 patient initiations are actually distributed across the timeline:The Cumulative Funnel: The "500 patients" is a cumulative figure spanning from the late 2024 launch through early 2026. It is not a single group that started at the exact same moment.Past Revenue Realization: A portion of those 500 patients have already finished treatment.revenue until March in J2026 won't yield revenue until June 2027.
0 · Reply
MangoBestFruit
MangoBestFruit Jul. 29 at 3:42 PM
$CRSP I’m in this for a swing let’s see
0 · Reply
Cannibal_Sluts_in_Space
Cannibal_Sluts_in_Space Jul. 29 at 2:17 PM
$CRSP https://www.youtube.com/watch?v=MyXGQLIlQnM
0 · Reply
Camgm
Camgm Jul. 29 at 11:19 AM
$CRSP feels like this Blackrock disclosure is a big deal? 8.3% ownership outweighs ARK doenst it?
3 · Reply
Nickmont
Nickmont Jul. 29 at 10:46 AM
$CRSP they likely won’t drop any PR out of the blue based on this company’s history and the nature of biotech. I would put like maybe 10% odds they give an update with earnings next week, but after that they likely won’t drop anything until medical conferences in November and December (ACR nov 6-11, AHA nov 6-9, ASH dec 12-15) which is why the price has been beaten down despite reports of many readouts to come this year.
0 · Reply
Stocktwits
Stocktwits Jul. 28 at 6:51 PM
$CRSP Love this trade idea from @peloswing!
0 · Reply
peloswing
peloswing Jul. 28 at 3:33 PM
$CRSP 8 Days of TIGHT Consolidation with Indicators Curling Needs some news to spark it and it could run $50+ very Quickly
0 · Reply
Cannibal_Sluts_in_Space
Cannibal_Sluts_in_Space Jul. 28 at 3:15 PM
$CRSP https://www.youtube.com/watch?v=bC3i_Vjy9To&list=RDbC3i_Vjy9To&start_radio=1
0 · Reply
Latest News on CRSP
3 Companies Redefining Healthcare Innovation

Jun 24, 2026, 7:41 AM EDT - 5 weeks ago

3 Companies Redefining Healthcare Innovation

CMPS VRTX


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 6 weeks ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Crispr Therapeutics price target raised to $82 from $80 at Citi

2026-05-07T08:40:23.000Z - 3 months ago

Crispr Therapeutics price target raised to $82 from $80 at Citi


Crispr Therapeutics reports Q1 EPS ($1.28), consensus ($1.23)

2026-05-04T20:48:53.000Z - 3 months ago

Crispr Therapeutics reports Q1 EPS ($1.28), consensus ($1.23)


CRISPR Therapeutics AG Earnings release: Q1 2026

May 4, 2026, 4:00 PM EDT - 3 months ago

CRISPR Therapeutics AG Earnings release: Q1 2026


CRISPR Therapeutics AG Quarterly report: Q1 2026

May 4, 2026, 4:00 PM EDT - 3 months ago

CRISPR Therapeutics AG Quarterly report: Q1 2026


CRISPR Therapeutics AG Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 3 months ago

CRISPR Therapeutics AG Proxy statement: Proxy filing


CRISPR Therapeutics AG Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 3 months ago

CRISPR Therapeutics AG Proxy statement: Proxy filing


Wall Street Is Completely Wrong About These 5 Stocks

Apr 9, 2026, 1:35 PM EDT - 3 months ago

Wall Street Is Completely Wrong About These 5 Stocks

HPQ HUT NVDA RCL


CRISPR Therapeutics AG Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 4 months ago

CRISPR Therapeutics AG Proxy statement: Proxy filing


Crispr Therapeutics falls -9.2%

2026-03-10T16:05:15.000Z - 5 months ago

Crispr Therapeutics falls -9.2%


CRISPR Therapeutics AG Annual report: Q4 2025

Feb 12, 2026, 4:00 PM EST - 5 months ago

CRISPR Therapeutics AG Annual report: Q4 2025


CRISPR Therapeutics AG Earnings release: Q4 2025

Feb 12, 2026, 4:00 PM EST - 5 months ago

CRISPR Therapeutics AG Earnings release: Q4 2025


CRISPR Therapeutics AG Earnings release: Q3 2025

Nov 10, 2025, 7:00 AM EST - 9 months ago

CRISPR Therapeutics AG Earnings release: Q3 2025


CRISPR Therapeutics AG Quarterly report: Q3 2025

Nov 10, 2025, 7:00 AM EST - 9 months ago

CRISPR Therapeutics AG Quarterly report: Q3 2025


CRISPR Therapeutics AG Slides: Corporate presentation

Nov 9, 2025, 7:00 AM EST - 9 months ago

CRISPR Therapeutics AG Slides: Corporate presentation


CRISPR Therapeutics AG Quarterly report: Q2 2025

Aug 4, 2025, 12:30 PM EDT - 1 year ago

CRISPR Therapeutics AG Quarterly report: Q2 2025


CRISPR Therapeutics AG Earnings release: Q2 2025

Aug 4, 2025, 12:30 PM EDT - 1 year ago

CRISPR Therapeutics AG Earnings release: Q2 2025


The Big 3: ASML, GOOGL, CRSP

Jul 15, 2025, 12:01 PM EDT - 1 year ago

The Big 3: ASML, GOOGL, CRSP

ASML GOOG GOOGL


The Big 3: CRSP, OKLO, GME

Jun 23, 2025, 12:01 PM EDT - 1 year ago

The Big 3: CRSP, OKLO, GME

OKLO GME


CRISPR Therapeutics AG Slides: Corporate Presentation

May 7, 2025, 7:00 AM EDT - 1 year ago

CRISPR Therapeutics AG Slides: Corporate Presentation


CRISPR Therapeutics AG Quarterly report: Q1 2025

May 6, 2025, 12:30 PM EDT - 1 year ago

CRISPR Therapeutics AG Quarterly report: Q1 2025


CRISPR Therapeutics AG Earnings release: Q1 2025

May 6, 2025, 12:30 PM EDT - 1 year ago

CRISPR Therapeutics AG Earnings release: Q1 2025


CRISPR Therapeutics AG Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

CRISPR Therapeutics AG Proxy statement: Proxy Filing


CRISPR Therapeutics AG Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

CRISPR Therapeutics AG Proxy statement: Proxy Filing


CRISPR Therapeutics AG Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

CRISPR Therapeutics AG Proxy statement: Proxy Filing


CRISPR Therapeutics AG Annual report: Q4 2024

Feb 11, 2025, 4:00 PM EST - 1 year ago

CRISPR Therapeutics AG Annual report: Q4 2024


CRISPR Therapeutics AG Earnings release: Q4 2024

Feb 11, 2025, 4:00 PM EST - 1 year ago

CRISPR Therapeutics AG Earnings release: Q4 2024


CRISPR Therapeutics AG Slides: FY 2025

Jan 14, 2025, 5:15 PM EST - 1 year ago

CRISPR Therapeutics AG Slides: FY 2025


CRISPR Therapeutics AG Quarterly report: Q3 2024

Nov 5, 2024, 9:00 AM EST - 1 year ago

CRISPR Therapeutics AG Quarterly report: Q3 2024


CRISPR Therapeutics AG Earnings release: Q3 2024

Nov 5, 2024, 9:00 AM EST - 1 year ago

CRISPR Therapeutics AG Earnings release: Q3 2024


CRISPR Therapeutics AG Quarterly report: Q2 2024

Aug 5, 2024, 4:00 PM EDT - 2 years ago

CRISPR Therapeutics AG Quarterly report: Q2 2024


CRISPR Therapeutics AG Earnings release: Q2 2024

Aug 5, 2024, 4:00 PM EDT - 2 years ago

CRISPR Therapeutics AG Earnings release: Q2 2024


Final Trade: UAL, NKE, SLV & CRSP

May 24, 2024, 7:40 PM EDT - 2 years ago

Final Trade: UAL, NKE, SLV & CRSP

SLV NKE UAL


CRISPR Therapeutics AG Slides: FY 2024

May 15, 2024, 12:20 PM EDT - 2 years ago

CRISPR Therapeutics AG Slides: FY 2024


CRISPR Therapeutics AG Quarterly report: Q1 2024

May 8, 2024, 4:00 PM EDT - 2 years ago

CRISPR Therapeutics AG Quarterly report: Q1 2024


CRISPR Therapeutics AG Earnings release: Q1 2024

May 8, 2024, 4:00 PM EDT - 2 years ago

CRISPR Therapeutics AG Earnings release: Q1 2024


CRISPR Therapeutics AG Proxy statement: Proxy Filing

Apr 9, 2024, 8:00 AM EDT - 2 years ago

CRISPR Therapeutics AG Proxy statement: Proxy Filing


CRISPR Therapeutics AG Proxy statement: Proxy Filing

Apr 9, 2024, 8:00 AM EDT - 2 years ago

CRISPR Therapeutics AG Proxy statement: Proxy Filing


CRISPR Therapeutics AG Proxy statement: Proxy Filing

Mar 27, 2024, 8:00 AM EDT - 2 years ago

CRISPR Therapeutics AG Proxy statement: Proxy Filing


Final Trade: HPQ, RSG, GM, CRSP

Mar 1, 2024, 6:21 PM EST - 2 years ago

Final Trade: HPQ, RSG, GM, CRSP

GM HPQ RSG


CRISPR Therapeutics AG Annual report: Q4 2023

Feb 21, 2024, 7:00 AM EST - 2 years ago

CRISPR Therapeutics AG Annual report: Q4 2023


CRISPR Therapeutics AG Earnings release: Q4 2023

Feb 21, 2024, 7:00 AM EST - 2 years ago

CRISPR Therapeutics AG Earnings release: Q4 2023


t5776
t5776 Jul. 29 at 9:17 PM
$CRSP Wall Street consensus models imply that as the backlog of 500+ global patient starts transitions into physical infusions, the program will clear net profit thresholds heavily in 2027.At current run rates, CRISPR is positioned to satisfy the entire $221.8 million cumulative liability by late 2027 or the first half of 2028, unlocking unencumbered 40% cash distributions to CRISPR’s balance sheet from that point forward.
0 · Reply
burbs88
burbs88 Jul. 29 at 7:03 PM
$CRSP Ya'll early...not wrong. Movie hasn't even started yet. Just the previews.
0 · Reply
t5776
t5776 Jul. 29 at 7:02 PM
$CRSP asked AI about the 500+ patients initiated…. Your mathematical intuition is 100% correct, but a key structural dynamic prevents that $1 billion figure from hitting the financial statements all at once.While 500 patients multiplied by a $2.2 million price tag technically represents $1.1 billion in total value, the timing of how patients enter the pipeline means this revenue will be recognized across multiple calendar years rather than squeezed into a single 12-month window.Breaking Down the MathTo understand why the $1 billion doesn't show up immediately, look at how the 500 patient initiations are actually distributed across the timeline:The Cumulative Funnel: The "500 patients" is a cumulative figure spanning from the late 2024 launch through early 2026. It is not a single group that started at the exact same moment.Past Revenue Realization: A portion of those 500 patients have already finished treatment.revenue until March in J2026 won't yield revenue until June 2027.
0 · Reply
MangoBestFruit
MangoBestFruit Jul. 29 at 3:42 PM
$CRSP I’m in this for a swing let’s see
0 · Reply
Cannibal_Sluts_in_Space
Cannibal_Sluts_in_Space Jul. 29 at 2:17 PM
$CRSP https://www.youtube.com/watch?v=MyXGQLIlQnM
0 · Reply
Camgm
Camgm Jul. 29 at 11:19 AM
$CRSP feels like this Blackrock disclosure is a big deal? 8.3% ownership outweighs ARK doenst it?
3 · Reply
Nickmont
Nickmont Jul. 29 at 10:46 AM
$CRSP they likely won’t drop any PR out of the blue based on this company’s history and the nature of biotech. I would put like maybe 10% odds they give an update with earnings next week, but after that they likely won’t drop anything until medical conferences in November and December (ACR nov 6-11, AHA nov 6-9, ASH dec 12-15) which is why the price has been beaten down despite reports of many readouts to come this year.
0 · Reply
Stocktwits
Stocktwits Jul. 28 at 6:51 PM
$CRSP Love this trade idea from @peloswing!
0 · Reply
peloswing
peloswing Jul. 28 at 3:33 PM
$CRSP 8 Days of TIGHT Consolidation with Indicators Curling Needs some news to spark it and it could run $50+ very Quickly
0 · Reply
Cannibal_Sluts_in_Space
Cannibal_Sluts_in_Space Jul. 28 at 3:15 PM
$CRSP https://www.youtube.com/watch?v=bC3i_Vjy9To&list=RDbC3i_Vjy9To&start_radio=1
0 · Reply
SternInvesting10
SternInvesting10 Jul. 28 at 2:10 PM
$NTLA beautiful weakness. This overvalued pig is finally unwinding. Scams getting exposed all over the place. $CRSP $ARKG
1 · Reply
DegenStock
DegenStock Jul. 28 at 1:37 PM
$CRSP some sort of update by management would be nice one of these days lol
1 · Reply
ChessGM
ChessGM Jul. 28 at 12:15 PM
$CRSP https://www.stocktitan.net/sec-filings/CRSP/schedule-13g-a-crispr-therapeutics-ag-amended-passive-investment-disc-db637e080984.html News for edgr.news
0 · Reply
dens214
dens214 Jul. 27 at 11:31 PM
$CRSP Day 27, H2,2026. 0 positive catalysts.
0 · Reply
thelasthope
thelasthope Jul. 27 at 11:25 PM
$CRSP CRISPR Therapeutics is actually a logical acquisition target because it has several things big pharmaceutical companies want: Why CRSP could attract a buyer 1. It owns a validated CRISPR platform Casgevy proved that CRISPR-based medicine can reach approval and commercialization. Many large pharma companies would rather buy a proven platform than spend years building one internally. 2. It has a pipeline, not just one drug Potential buyers would be looking at: sickle cell/beta thalassemia franchise (Casgevy) autoimmune programs oncology programs cardiovascular gene-editing programs 3. Biotech M&A often happens when valuations are depressed
1 · Reply
Cannibal_Sluts_in_Space
Cannibal_Sluts_in_Space Jul. 27 at 8:09 PM
$CRSP LOL! freefall into the close... I swear to God, the REAL goal around here is to flounder until the bull market is over...
0 · Reply
thelasthope
thelasthope Jul. 27 at 7:25 PM
$CRSP Peak bearishness. Had sold at high 50s. Bought back in :)
0 · Reply
handmedown1
handmedown1 Jul. 27 at 12:53 PM
$CRSP i can't believe these guys
0 · Reply
AdmiralTweezers
AdmiralTweezers Jul. 25 at 3:13 PM
$CRSP https://youtube.com/shorts/3UDZCM8kJbs?is=OOBWo08QsE_LVxgd
0 · Reply
SternInvesting10
SternInvesting10 Jul. 24 at 8:09 PM
$NTLA $CRSP Limit down Monday $DKNG $CELH Markets down 5%, speculative growth stocks down 25% $ARKK will be sliced in half in one month from now. The great financial crisis of the 2020's is here. Slaughterhouse time.
1 · Reply
NotEnoughChips
NotEnoughChips Jul. 24 at 7:40 PM
$CRSP scoop up those shares!
0 · Reply